bpc-157 human studies safety evidence for athletes and injury treatment: Science, safety, and legal concerns BPC-157 – No Proof Required!

Bcl-2 is posited as an anti-apoptotic protein that apparently inhibits cell death, while Bax is suggested to be a pro-apoptotic protein that promotes cell death

Investigators continue to study BPC-157 for its influence on cellular communication, angiogenic signaling, tissue remodeling, and the complex biological processes involved in maintaining tissue homeostasis following physiological stress

Chemical class Small-molecule quinolinium compound Peptide status Not a peptide Primary research target Nicotinamide N-methyltransferase Common abbreviation 5A1MQ or 5-AMQ Evidence level Cell and animal research Human trials No controlled human trial identified UK approval No marketing authorisation identified Main evidence warning Mouse outcomes do not establish human results What Is 5-Amino-1MQ

No blood or blood products are involved

Werner's Syndrome: From Clinics to Genetics. Clinical and Experimental Rheumatology 18, no